In summary, when considered together with data showing NFYB as protective against E2F1-mediated apoptosis, this analysis suggests that the joint E2F1/NFYB transcriptional program may play a role in cancer resistance to chemotherapy. The gene discussed is NFYB; the disease is cancer.